European Innovation Council

The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.

David Malo Jean

Director

Candace Johnson

President

Past deals in Wireless

Hideez

Grant in 2024
Hideez is a cybersecurity startup that specializes in providing solutions for both physical and logical access. With offices in the USA and Ukraine, the company has developed the Hideez Key, a hybrid device designed for wireless authentication and password management. This innovative solution integrates RFID door credentials and digital signatures, utilizing encrypted Bluetooth, RFID, and NFC technologies. Hideez Key offers a versatile approach to authentication, enabling users to manage and replace credentials remotely. Its proprietary encryption protocols are platform agnostic and are designed to enhance existing solutions in the market. Overall, Hideez aims to simplify identity and access management while ensuring the security of digital assets.

Afon Technology

Grant in 2022
Afon Technology provides non-invasive blood glucose monitoring devices. Their services are non-invasive, pain-free, blood glucose tracking in real-time, continuous detection, potential pre-diabetic identification, alarm alerts, trend profiles, and time-in-range profiles, bluetooth connectivity to smart devices, ios, and android compatible stand-alone sensors, and user interface via app on smart device services.

CorWave

Venture Round in 2022
CorWave is a developer of advanced implanted cardiac support devices aimed at improving the quality of life for patients with heart failure. The company's flagship product, an innovative left ventricular assist device (LVAD), employs a unique undulating disc wave pumping mechanism. This design enhances blood flow by mimicking the natural pulsation of the heart, significantly reducing trauma to blood and minimizing complications associated with clotting and bleeding, which are common with traditional continuous flow pumps. Additionally, CorWave's LVAD is characterized by low power consumption and compact size, making it suitable for complete implantation and integration with a wireless energy transfer system. Through its pioneering technology, CorWave seeks to alleviate the burdens of heart failure and lessen the need for invasive surgical interventions.

Fineheart

Grant in 2022
Fineheart is a France-based medical device company that specializes in innovative technologies aimed at addressing cardiovascular diseases. The company is developing an implantable cardiac device that is wirelessly powered and fully implantable, designed to provide mechanical circulatory support. This novel device optimizes cardiac output while preserving the heart's natural contractility, thereby enabling patients with heart failure to restore normal cardiac function and improve their quality of life. Fineheart's focus on advanced medical solutions positions it as a key player in the evolving landscape of cardiovascular care.

Fineheart

Series C in 2022
Fineheart is a France-based medical device company that specializes in innovative technologies aimed at addressing cardiovascular diseases. The company is developing an implantable cardiac device that is wirelessly powered and fully implantable, designed to provide mechanical circulatory support. This novel device optimizes cardiac output while preserving the heart's natural contractility, thereby enabling patients with heart failure to restore normal cardiac function and improve their quality of life. Fineheart's focus on advanced medical solutions positions it as a key player in the evolving landscape of cardiovascular care.

Hexagem

Grant in 2022
Hexagem is working with a number of industrial partners to bring their substrate technology into high quality devices for RF applications. They are interested to expand their current network of industrial partners with high quality partners with strong RF device expertise.

Ignion

Venture Round in 2022
Ignion is an antenna innovator based in Sant Cugat del Vallès, Spain, founded in 2015. The company specializes in manufacturing multiband, multipurpose antennas that cater to mobile and wireless connectivity requirements. Its product offerings include ready-to-use antennas designed for Internet of Things applications and short-range wireless devices, particularly suited for indoor environments. Ignion's solutions allow clients to seamlessly integrate these antennas into their industrial designs, facilitating efficient connectivity in various applications.

Oledcomm

Grant in 2021
Oledcomm specializes in designing and developing LiFi solutions that facilitate high-speed optical wireless data communication, targeting sectors such as aerospace and industrial markets. Founded in 2012 and re-established in February 2020 by Benjamin Azoulay, the company is headquartered in Paris, France. Its product range includes LiFi transceivers and software, which enable efficient and environmentally friendly wireless communication. Oledcomm's technology converts information into binary data, similar to optical Morse code, allowing seamless connectivity for various applications in telecom, datacom, and personal electronics.

Intelligent Implants

Grant in 2021
Intelligent Implants, founded in 2014 in Cork, Ireland, specializes in the development of wireless implantable electronics designed to stimulate, steer, and monitor bone growth. The company focuses on creating electrotherapeutic devices that not only treat diseases but also support the recovery of bone and other tissues. By integrating data, engineering, and medicine, Intelligent Implants aims to deliver innovative, active, and connected medical devices that enhance patient treatment and facilitate decision-making for healthcare professionals. Their technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to effectively utilize electrotherapeutics to monitor and control patient conditions, ultimately leading to more timely and informed medical interventions.

ONiO

Venture Round in 2020
ONiO is a semiconductor company focused on creating self-powered, batteryless solutions for the Internet of Things (IoT) market. The company develops wireless microcontrollers that harness energy from their environment, allowing IoT devices to operate without traditional batteries. This innovation aims to facilitate a transition to a battery-free ecosystem, making health-related information more accessible and easier to understand. By reducing the barriers between people and healthcare technology, ONiO empowers individuals to take greater control of their health while minimizing distractions from other aspects of their lives.

ONiO

Grant in 2020
ONiO is a semiconductor company focused on creating self-powered, batteryless solutions for the Internet of Things (IoT) market. The company develops wireless microcontrollers that harness energy from their environment, allowing IoT devices to operate without traditional batteries. This innovation aims to facilitate a transition to a battery-free ecosystem, making health-related information more accessible and easier to understand. By reducing the barriers between people and healthcare technology, ONiO empowers individuals to take greater control of their health while minimizing distractions from other aspects of their lives.

Xsensio

Venture Round in 2020
Xsensio is a digital health company focused on addressing the challenge of real-time, continuous monitoring of health parameters. It is developing an innovative Lab-on-Skin wearable device that serves as a miniaturized sensing platform, enabling continuous and real-time analysis of biochemical information at the skin's surface. This technology allows for the precise measurement of various health indicators, such as electrolytes, metabolites, hormones, and proteins, akin to traditional blood tests but in a minimally invasive manner. By providing unprecedented insights during critical health events, Xsensio aims to enhance patient care and shift the healthcare industry from a static to a dynamic approach in health monitoring.

Xsensio

Grant in 2020
Xsensio is a digital health company focused on addressing the challenge of real-time, continuous monitoring of health parameters. It is developing an innovative Lab-on-Skin wearable device that serves as a miniaturized sensing platform, enabling continuous and real-time analysis of biochemical information at the skin's surface. This technology allows for the precise measurement of various health indicators, such as electrolytes, metabolites, hormones, and proteins, akin to traditional blood tests but in a minimally invasive manner. By providing unprecedented insights during critical health events, Xsensio aims to enhance patient care and shift the healthcare industry from a static to a dynamic approach in health monitoring.

CorWave

Venture Round in 2020
CorWave is a developer of advanced implanted cardiac support devices aimed at improving the quality of life for patients with heart failure. The company's flagship product, an innovative left ventricular assist device (LVAD), employs a unique undulating disc wave pumping mechanism. This design enhances blood flow by mimicking the natural pulsation of the heart, significantly reducing trauma to blood and minimizing complications associated with clotting and bleeding, which are common with traditional continuous flow pumps. Additionally, CorWave's LVAD is characterized by low power consumption and compact size, making it suitable for complete implantation and integration with a wireless energy transfer system. Through its pioneering technology, CorWave seeks to alleviate the burdens of heart failure and lessen the need for invasive surgical interventions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.